Statistics for Core Laboratories NV (id:9686 CLB)

Valuation metrics

Market cap

917.40M

Enterprise value

1.10B

Trailing P/E (ttm)

36.19

Forward P/E

19.94

PEG ratio

19.94

Price/Sales (ttm)

1.75

Price/Book (mrq)

3.66

Enterprise Value/Revenue

2.10

Enterprise Value/EBITDA

15.36

Overview

Shares outstanding

46.95M

Float

46.53M

Shares short

6.95M

% Held by insiders

0.01%

% Held by institutions

1.12%

Average volume (10 days)

311.04K

Average volume (90 days)

Price summary

52-Week low

13.82

52-Week high

25.13

52-Week change

12.52%

Beta

2.36

50-Day moving average

18.92

200-Day moving average

18.31

Dividends and splits

Forward annual dividend rate

0.04

Forward annual dividend yield

0.00

Trailing annual dividend rate

0.04%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

1.51

Payout ratio

0.07

Dividend date

November 25th, 2024

Ex-dividend date

November 04th, 2024

Last split factor

2:1

Last split date

July 09th, 2010

Financials

Fiscal year

Fiscal year ends

December 31th, 2023

Most recent quarter (mrq)

September 30th, 2024

Profitability

Profit margin

5.01%

Operating margin

12.35%

Operational effectiveness

Return on assets

5.89%

Return on equity

11.16%

Income statement

Revenue (ttm)

11.16

Revenue per share (ttm)

11.16

Quarterly revenue growth (yoy)

0.27

Gross profit (ttm)

94.05M

EBITDA

71.62M

Net income to common (ttm)

26.20M

Diluted EPS (ttm)

0.54

Quarterly earnings growth (yoy)

26.90%

Balance sheet

Total cash (mrq)

21.47M

Total cash per share (mrq)

0.46

Total debt (mrq)

195.03M

Total Debt/Equity (mrq)

76.06

Current ratio (mrq)

247.80%

Book value per share (mrq)

5.34

Cash flow

Cash flow statement

55.20M

Levered free cash flow (LFCF)

43.78M